Related Experiment Video
Updated: Nov 29, 2025

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Bilateral Pallidotomy for Dystonia: A Systematic Review
Liesanne M Centen1, D L Marinus Oterdoom1, Marina A J Tijssen2,3
1Department of Neurosurgery, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Bilateral pallidotomy offers effective treatment for dystonia, especially medication-refractory status dystonicus. This surgical option provides a viable alternative for patients ineligible for deep brain stimulation (DBS).
Area of Science:
- Neurosurgery
- Neurology
- Movement Disorders
Background:
- Stereotactic bilateral globus pallidus (GPi) lesioning was an early surgical treatment for dystonia.
- Deep brain stimulation (DBS) has largely replaced pallidotomy, but not all dystonia patients are candidates for DBS.
- Bilateral pallidotomy remains a relevant consideration for specific patient groups.
Purpose of the Study:
- To systematically review the efficacy, safety, and sustainability of bilateral pallidotomy.
- To evaluate outcomes using individual patient data (IPD) for a comprehensive analysis.
- To assess bilateral pallidotomy as an alternative surgical treatment for dystonia.
Main Methods:
- Systematic review of individual patient data (IPD) following PRISMA guidelines.
- Searched Medline, Embase, Web of Science, and Cochrane Library for relevant studies up to May 2020.
- Analyzed data from 100 patients across 33 articles, collecting IPD where available.
Main Results:
- Bilateral pallidotomy showed a clinically relevant improvement (>20%) in 79% of 53 patients assessed.
- Adverse events occurred in 20% of patients, with 8% experiencing permanent adverse events.
- Status dystonicus (SD) resolved in most patients (23/25), though 7 experienced relapse.
Conclusions:
- Bilateral pallidotomy is an effective and relatively safe procedure for specific dystonia types, particularly medication-refractory status dystonicus.
- Despite potential publication bias, it represents a reasonable alternative to DBS for selected dystonia patients.
- The sustainability of outcomes requires further investigation beyond the median 12-month follow-up.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Depolarizing Blockers: Pharmocokinetics
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...

